Recursion Pharmaceuticals (RXRX) Q3 2025 Earnings

5AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.53
-0.46
-0.4
-0.33

Details

Expected EPS
-0.353333
Actual EPS
-0.41
Surprise EPS
-0.06
Surprise Percent
+16.04%

Description

Recursion Pharmaceuticals (RXRX) has reported earnings of -0.41 per share for Q3 2025.

0 Comments

Share your thoughts